Complete Regression of Hepatocellular Carcinoma with Low Dose of Sorafenib

被引：1
|
作者：
Mahajan, Abhishek [1 ]
Shetty, Athish [1 ]
Koteshwar, Prakashini [2 ]
Musunuri, Balaji [1 ]
Shetty, Shiran [1 ]
Bhat, Ganesh [1 ]
机构：
[1] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Gastroenterol, Manipal 576104, India
[2] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Radiodiag, Manipal 576104, India
来源：
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY | 2021年 / 11卷 / 06期
关键词：
D O I：
10.1016/j.jceh.2021.06.012
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：756 / 757
页数：2
相关论文
共 50 条
  • [31] Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study
    Norio Itokawa
    Masanori Atsukawa
    Akihito Tsubota
    Tomomi Okubo
    Taeang Arai
    Ai Nakagawa
    Chisa Kondo
    Katsuhiko Iwakiri
    International Journal of Clinical Oncology, 2016, 21 : 676 - 683
  • [32] Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study
    Itokawa, Norio
    Atsukawa, Masanori
    Tsubota, Akihito
    Okubo, Tomomi
    Arai, Taeang
    Nakagawa, Ai
    Kondo, Chisa
    Iwakiri, Katsuhiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (04) : 676 - 683
  • [33] Complete response to low-dose sorafenib in a patient with metastatic renal cell carcinoma: A case report
    Morita, Jun
    Naoe, Michio
    Ogawa, Yu
    Nakasato, Takehiko
    Sugahara, Motoko
    Morita, Masashi
    Fuji, Kohzo
    Fukagai, Takashi
    Sasaki, Haruaki
    Ogawa, Yoshio
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2013, 7 (5-6): : E351 - E354
  • [34] Effects of Sorafenib Dose on Acquired Reversible Resistance and Toxicity in Hepatocellular Carcinoma
    Kuczynski, Elizabeth A.
    Lee, Christina R.
    Man, Shan
    Chen, Eric
    Kerbel, Robert S.
    CANCER RESEARCH, 2015, 75 (12) : 2510 - 2519
  • [35] Complete response of advanced hepatocellular carcinoma achieved by sorafenib dose re-escalation after failure of long-term low-dose-sorafenib treatment combined with transcatheter arterial chemoembolization: a case report
    Hisanori Muto
    Teiji Kuzuya
    Takanori Ito
    Yoji Ishizu
    Takashi Honda
    Tetsuya Ishikawa
    Masatoshi Ishigami
    Mitsuhiro Fujishiro
    Clinical Journal of Gastroenterology, 2020, 13 : 397 - 402
  • [36] Complete response of advanced hepatocellular carcinoma achieved by sorafenib dose re-escalation after failure of long-term low-dose-sorafenib treatment combined with transcatheter arterial chemoembolization: a case report
    Muto, Hisanori
    Kuzuya, Teiji
    Ito, Takanori
    Ishizu, Yoji
    Honda, Takashi
    Ishikawa, Tetsuya
    Ishigami, Masatoshi
    Fujishiro, Mitsuhiro
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2020, 13 (03) : 397 - 402
  • [37] Low Pi stress enhances the sensitivity of hepatocellular carcinoma to sorafenib
    Bi, Qiu-Chen
    Deng, Zhi-Qiang
    Lv, Yang-Feng
    Liu, Yue
    Xie, Chuan-Sheng
    He, Yuan-qiao
    Tang, Qun
    BIOCHEMICAL PHARMACOLOGY, 2023, 213
  • [38] Regression of Hepatocellular Carcinoma With Right Atrial Extension After Sorafenib and Transarterial Chemoembolization
    Subramanian, Madhu
    Singal, Amit G.
    Yopp, Adam C.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (10) : E83 - E84
  • [39] Complete Histologic Response Induced by Sorafenib in Advanced Hepatocellular Carcinoma: A Case Report
    Curtit, Elsa
    Thiery-Vuillemin, Antoine
    Nguyen, Thierry
    Heyd, Bruno
    Pivot, Xavier
    Di Martino, Vincent
    Borg, Christophe
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (12) : E330 - E332
  • [40] Complete and Sustained Off-Therapy Response to Sorafenib in Advanced Hepatocellular Carcinoma
    Maida, Marcello
    Macaluso, Fabio Salvatore
    Valenza, Franco
    Virdone, Roberto
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2016, 25 (02) : 253 - 255
12345